Ad is loading...
CRCRX
Price
$10.41
Change
+$0.05 (+0.48%)
Updated
Nov 22 closing price
VGSNX
Price
$21.12
Change
+$0.18 (+0.86%)
Updated
Nov 22 closing price
Ad is loading...

CRCRX vs VGSNX

Header iconCRCRX vs VGSNX Comparison
Open Charts CRCRX vs VGSNXBanner chart's image
NYLI CBRE Real Estate
Price$10.41
Change+$0.05 (+0.48%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Institutional
Price$21.12
Change+$0.18 (+0.86%)
VolumeN/A
CapitalizationN/A
CRCRX vs VGSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CRCRX vs. VGSNX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRCRX is a Buy and VGSNX is a Buy.

FUNDAMENTALS
Fundamentals
VGSNX has more cash in the bank: 68.9B vs. CRCRX (296M). VGSNX pays higher dividends than CRCRX: VGSNX (4.01) vs CRCRX (1.92). CRCRX was incepted earlier than VGSNX: CRCRX (22 years) vs VGSNX (21 years). CRCRX is a more actively managed with annual turnover of: 65.00 vs. VGSNX (9.00). CRCRX has a lower initial minimum investment than VGSNX: CRCRX (1000) vs VGSNX (5000000). VGSNX annual gain was more profitable for investors over the last year : 26.24 vs. CRCRX (21.04). VGSNX return over 5 years is better than : 27.07 vs. CRCRX (-19.42).
CRCRXVGSNXCRCRX / VGSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years21 years-
Gain YTD7.08512.28558%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets296M68.9B0%
Annual Yield % from dividends1.924.0148%
Returns for 1 year21.0426.2480%
Returns for 3 years-30.71-1.192,575%
Returns for 5 years-19.4227.07-72%
Returns for 10 years-40.3070.08-58%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLSI13.550.58
+4.47%
Greenwich LifeSciences
SNA365.974.57
+1.26%
Snap-on
EWTX32.200.22
+0.69%
Edgewise Therapeutics
RDWR23.17-0.01
-0.04%
Radware Ltd
IMRN1.88-0.03
-1.53%
Immuron Limited